Ohio State Navbar

Dr. Woyach, Dr. Johnson, and Dr. Byrd Receive Alliance BTK RO1 Grant from the NIH


Co-PIs Dr. Jennifer Woyach, Dr. Amy Johnson, and Dr. John Byrd Receive Alliance BTK RO1 Grant from the NIH for "Molecular Evaluation of Targeted Therapies in Lymphoid Malignancies."

This grant supports a Phase III clinical trial investigating ibrutinib alone or ibrutinib plus rituximab compared with standard therapy of bendamustine plus rituximab (BR) in older patients with previously untreated CLL.